BridgeBio Pharma, Inc. Increase (Decrease) in Other Current Liabilities
BridgeBio Pharma, Inc. (BBIO) reported Increase (Decrease) in Other Current Liabilities of $26.61 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2025-08-05
- BridgeBio Pharma, Inc. increase (decrease) in other current liabilities for the quarter ending 2025-06-30 was $23.66M, a 14155.42% increase year-over-year.
- BridgeBio Pharma, Inc. increase (decrease) in other current liabilities for the quarter ending 2025-03-31 was $2.94M.
- BridgeBio Pharma, Inc. increase (decrease) in other current liabilities for the quarter ending 2024-06-30 was $166.00K.
- BridgeBio Pharma, Inc. increase (decrease) in other current liabilities for the quarter ending 2024-03-31 was -$1.26M.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month |
|---|---|---|
| 2025-06-30 | $23.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $26.61M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $2.94M 10-Q · filed 2025-04-29 | |
| 2024-06-30 | $166.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$1.09M 10-Q · filed 2025-08-05 |
| 2024-03-31 | -$1.26M 10-Q · filed 2025-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |